Skip to main content
Fig. 13 | Cancer Nanotechnology

Fig. 13

From: Preparation and characterization of the myricetin-loaded solid lipid nanoparticles decorated with folic acid-bound chitosan and evaluation of its antitumor and anti-angiogenic activities in vitro and in vivo in mice bearing tumor models

Fig. 13

H&E staining of liver and tumor from TUBO tumor model, which subcutaneously inoculated in the right flank of mice. The animals were treated with free myricetin and doses of 25 and 50 mg/kg of myricetin-SLN-CS-FA (SLN-25 and SLN-50). The samples were investigated under 100× and 400× magnification fields

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us